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Case RepoRt
A 60-year-old woman, in menopause for about ten years, came 
to our clinic complaining of pelvic discomfort and about 12 kg of 
progressive weight loss but no specific symptoms of gastrointestinal 
disease. She did not have a family history of malignancy and no 
significant past history. An abdominal examination showed no 
palpable masses and the breast examination was normal. The 
gynaecological examination of the vagina, uterus and adnexal left 
field was normal, while the adnexal right field was larger in size. 
An abdomen ultrasound confirmed an ill-defined heterogeneous 
ovarian mass and her chest radiograph was normal.
The following haematological tumour markers were normal: 
Carcinoembryonic Antigen (CEA): 2.9ng/ml (Normative values: 
<5ng/ml), Cancer Antigen 125 (CA125): 16.3U/ml (Normative 
values: <30.2U/ml), Carbohydrate Antigen (CA19.9): 12,90U/ml 
(Normative values: <35.00 U/ml), HE4 (Human epididymis protein 
4): 60pmol/l (Normative values: ≤140pmol/l). In addition, the ROMA 
index (Risk of Ovarian Malignancy Algorithm) [1] indicated that the 
patient had a low risk of developing ovarian cancer.
An MRI scan with contrast of the lower abdomen and pelvic region 
revealed a complex solid mass in the right adnexal with an irregular 
structure and pronounced enhancement. The uterus (with cervix) 
and the left tube appeared normal. No lymph nodes were palpable 
[Table/Fig-1].
After recurrent episodes of metrorrhagia, transvaginal ultrasono-
graphy (TVS) confirmed the presence of a solid mass (9.2X7.2cm) 
in the right ovary while the left ovary was regular (2.7X1.2cm) with 
a compact echo structure. The patient underwent a diagnostic 
uterine hysteroscopy with an endometrial biopsy which showed 
no neoplastic elements and only endometrium hypotrophic 
fragments. The cytology pap-test did not reveal any alterations. 
The patient underwent an exploratory surgery and the 
extemporaneous examination of the right ovary showed a smooth 
surface completely replaced by an encapsulated neoplasm 
mass measuring 10X7X3cm in size, compatible with a poorly 
differentiated adenocarcinoma. She underwent a total extra fascial 
abdominal hysterectomy, a bilateral salpingo-oophorectomy, 
an upper third colpectomy and omentectomy, with a bilateral 
pelvic lymphadenectomy. Para-aortic-caval nodes explorations, 
peritoneal fluid sampling and a bilateral pelvic and a sub-
diaphragmatic biopsy were performed.
The surgical specimen from the right ovary, after paraffin 
embedding, showed poorly differentiated adenocarcinoma with 
mucin-containing signet-ring cells (AFN-SRs). Peritoneal washing 
cytology was negative for neoplastic cells. Uterus, peritoneum and 
omentum and lymph nodes did not show any neoplastic infiltrations, 
but the biopsy revealed the presence of an adenocarcinoma in the 
left ovary and tube which contained variable numbers of Signet 
Ring Cells (SRCC) [Table/Fig-2a&b]. The histologic examination 
has led to Stage pT2aNxMx (FIGO IIA). Immunostaining showed 
positive CK7, CK20, CKPan markers but ER, Ca125, inhibin alpha, 
actin and desmin were negative. 
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aBstRaCt
Krukenberg tumours are rare metastatic tumours of the ovaries characterized by the presence of mucin-producing neoplastic Signet 
Ring Cell Carcinoma (SRCC). At first glance, this tumour may be confused with a primary ovarian tumour. Surgery and chemotherapy 
combination have led to improvement in prognosis, but it still remains severe. We report the case of a 60-year-old woman with a 
Krukenberg tumour rising from a low differentiated gastric adenocarcinoma. The patient was clinically stable for 26 months after surgery 
until she experienced a prompt decline and died of cerebral haemorrhage within two weeks. The aim of this article was to give an 
overview of the Krukenberg tumour starting from our case report and comparing it with clinicopathological characteristics of this 
pathology derived from a review of recent literature.
[table/Fig-1]: Magnetic resonance imaging showed large pelvic mass arising from the right adnexa.
[table/Fig-2a,b]: Krukenberg tumor showing signet-ring cells. A: magnification 10X; B: magnification 40X.
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Due to the histological results, we suspected a Krukenberg tumour 
thus a contrast-enhanced computed tomography scan of the 
neck, chest and abdomen was performed. Multiple and scattered 
lymphadenomegaly were found at the thoracic level (prevascular, 
paratracheal, precarinal, sub carinal and right paraesophageal 
regions). The CT showed wall thickening in the pre-antral region 
of the abdomen (3cm wide and with a maximum thickness of 
13mm), multiple nodules at the gastrohepatic and gastrocolic 
ligaments and the presence of intercaval-aortic and para-aortic 
left lymphadenomegaly. The CT did not reveal any parenchymal 
metastasis. The patient underwent a colonoscopy which was 
negative. In order to detect a primary GI malignancy, an E.G.D.S. 
(esophagogastroduodenoscopy) was performed: it revealed 
the presence of a small whitish ulcerated lesion with a fibrinous 
substratum, and recognized profits in the gastric body and chronic 
gastritis supported by Helicobacter pylori [Table/Fig-3].
The histopathology of the biopsy specimen revealed a poorly 
differentiated gastric adenocarcinoma with signet ring cells and 
finally, a metastatic gastric adenocarcinoma with a Krukenberg 
tumour was diagnosed.
A bone scintigraphy of whole-body scan with (99m) technetium-
hydroxymethylene diphosphonate identified multiple skeletal 
lesions with osteo-thickener characteristics diffused in various 
skeletal segments: the skull, clavicles, shoulder blades, shoulders, 
the whole spine, numerous ribs, the pelvis and the proximal femur. 
In view of the stadium and immunohistochemical characteristics 
of the disease, the patient was treated with chemotherapy 
oxaliplatinum (148mg) and 5-fluorouracil (4872mg) with 14-day 
cycles.  A total body CT, performed nine months after surgery, 
was stationary; also the EGDS showed no presence of lesions 
[Table/Fig-4]. No suspicious lesions were documented and a 
mediastinal lymphadenopathy of reduced dimensions as well 
as an abdomen CT and skeletal lesions showed no significant 
changes or aggravations, contrarily the multiple lesions showed 
a shading aspect. 
Till the next 26 months post-surgery the patient was clinically 
stable. Unfortunately, the patient experienced a rapid deterioration 
of her condition within a span of 10 days and she visited us. On 
investigation it was found that there was a massive metastatic 
spread to the bone marrow. The patient died of cerebral 
haemorrhage due to Disseminated Intravascular Coagulation (DIC) 
within the next two weeks [Table/Fig-5].
DIsCUssIoN 
Krukenberg tumours are unusual metastatic tumours of the 
ovaries first described by Friedrich Krukenberg in 1896. In 1902, 
Schlagenhaufer emphasized that these ovarian tumours do not 
originate in the ovary, but are metastases from a primary malignancy 
somewhere else. Moreover, Schlagenhaufer stated that the most 
common primary site is the gastrointestinal tract [2].
Nowadays, the term ‘‘Krukenberg tumour’’ indicates any ovarian 
metastatic carcinoma deriving from a primary malignancy. 
However, the World Health Organization’s diagnostic criteria states 
that a diagnosis of a Krukenberg tumour is based on the presence 
of stromal involvement, mucin-producing neoplastic Signet Ring 
Cells (SRCC) and ovarian stromal sarcomatoid proliferation [3].
The finding of a malignant ovarian tumour poses an immediate 
clinical question: is it primary or metastatic? The management 
and the prognosis of the disease varies depending on the 
primary tumour; therefore, therefore, it is essential to identifying 
it promptly. Krukenberg tumours are not common and they only 
represent 1-2% of all ovarian tumours [4]; estimated incidence of 
these tumours is approximately 0.16 per 100000 per year [5]. The 
majority of the patients are between the ages of 20 years and 60 
years and it is more common in premenopausal women than in 
postmenopausals. There are some several reports of Krukenberg 
cancer during pregnancy with bad prognosis [6,7]. 
Regarding the average age, affected patients were relatively 
young: on 23 patients (including the indexed case), 10 patients 
were younger than 40 years, 7 patients are aged between 41-
50 years and 6 patients were older than 50 years; moreover, 3 
patients out of 23 (13,04%) were pregnant.
Krukenberg tumours are rare during pregnancy, but generally 
predict a serious prognosis [8]. Diagnosis is difficult because 
presenting symptoms are often attributed to pregnancy like 
worsening abdominal pain, ascites and virilization. The tumour 
may be confused with other adnexal masses such as teratomas 
and corpus luteum cysts, which are common during pregnancy 
[8,9]. 
The major signs of metastasis are: bilaterality (of 74% has bilateral 
ovarian cancer and 26% has unilateral tumour); size of the injury 
(less than 10 cm); surface involvement; extensive intra-abdominal 
spread and a widespread infiltrative pattern. On the contrary, only 
two morphological patterns exclude a primitive origin: the presence 
of colloid and signet ring cells. The features favouring primary 
origin are unilaterality, size greater than 12 cm, a smooth external 
surface and often association with other ovarian pathologies [10].
Many patients initially report symptoms of metastases instead of a 
primary tumour. Symptoms are abdominal swelling and discomfort, 
weight loss, respiratory distress, chest pain, followed by nausea, 
vomiting or epigastric pain [11]. In addition, physical examinations 
often reveal the presence of abdominal or pelvic masses.
[table/Fig-3]: Esophagogastoduodenoscopy releaved ulcerated lesion with a fibrinous substratum in the body of the stomach before treatment.
[table/Fig-4]: Esophagogastoduodenoscopy showed the absence of the lesion after treatment.
[table/Fig-5]: Cranial CT scan showed a transfalcial ernation with axial deviation due to cerebral hemorrhage.
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The literature analysis revealed that 16 patients out of 23 (69,56%) 
had abdominal discomfort or pain; 35% of the total patients 
showed abdominal or pelvic mass and in the remaining cases, the 
patients had other symptoms such as pelvic pain, hypermenorrhea, 
nausea and vomiting, 52% patients had ascites at the time of 
diagnosis and it appeared like Pseudo-Meigs’ Syndrome in two 
patients [12,13].
In many instances, ovarian cancer may be the first sign of a tumour 
process originated elsewhere several years before [4,8,12-30]. 
Specifically, signet ring cell mucinous carcinomas of the ovary are 
mostly metastases of the stomach, the pancreas, the biliary tract 
and the appendix. They can be colorectal tumours and primary 
tumours of the urinary bladder, of renal pelvis and of uterine cervix. 
Corpus or mammary tumours with signet ring cells and bone 
metastases are very rare [15]. Occasionally, the primary tumour is 
never discovered [14].
Three possible metastasis pathways have been identified: 
lymphatic, haematogenous, and transcoelomic metastasis, but 
the retrograde lymphatic spread has been demonstrated to be the 
most likely pathway [2,6,31,32].
When a Krukenberg tumour is suspected, accurate examinations 
of the gastrointestinal organs should be conducted and it is 
important to look for the presence of primary tumours. For this 
purpose, the main imaging techniques employed to make a 
diagnosis of a Krukenberg tumour are: a pelvic ultrasound, a CT 
and a pelvic MRI, but they are not specific enough because the 
tumour reveals mostly solid components, or a mixture of cystic 
and solid areas [16].
Transabdominal sonography of abdomen and pelvis is primary imaging 
and screening modality for females with gynaecological illness [4]. 
With a pelvic ultrasound, Krukenberg tumours are typically seen as 
solid ovarian masses, with clear well-defined margins. A characteristic 
feature is an irregular hyperechoic solid pattern and a moth eaten like 
cyst formation. Another suggestive sign is the presence of a large 
lead vessel penetrating the mass from the periphery and nourishing 
the tumour by branching in tree pattern, known as lead vessel sign, 
with high speed and low resistance on spectral Doppler. This colour 
Doppler sign is more frequently detected in ovarian metastases 
compared with primary invasive ovarian carcinomas. Sonography 
and colour Doppler imaging are decisive in rising the suspicion of a 
metastatic tumour [4].
Krukenberg tumours may show some typical features on an MRI, 
such as bilateral, lobulated and solid masses. On T2-weighted 
MR images, the solid tumour components typically show 
heterogeneously low to high signal intensity. Areas of decreased 
intensity are either randomly or peripherally located, histologically 
corresponding to increased cellularity seen with fibrous stroma, 
while areas of increased intensity represent edema within the 
connective tissue. Signal voids can frequently be observed within 
the tumours, representing increased tumour vascularity. At both 
contrast-enhanced CT and T1-weighted MR imaging, the solid 
components usually demonstrate homogeneous enhancement 
[31]. Moreover, tumours originating from the stomach may be 
denser on a contrast-enhanced CT than those originating from 
the colon [33,34].
Microscopically, metastatic tumours show a variety of patterns 
according to the site of the primary tumour. Pathological reports 
describe metastatic tumours as about 60% of cases being lesions 
that appear as diffusely solid tumours, multiple solid nodules, 
partially cystic masses or, rather infrequently, completely cystic 
lesions. Even when the primary tumour is solid, metastases 
in the ovaries may be cystic or semi cystic. Extensive areas of 
haemorrhage and/or necrosis are common [26,35]. The lesion 
often reveals surface implants marked by numerous bosses and 
vascular invasion. 
A pathognomonic diagnostic feature of a Krukenberg tumour 
is the presence of mucin-filled signet-ring cells associated with 
a conspicuous proliferation of cellular non-neoplastic ovarian 
stroma. Epithelial elements other than the signet-ring cells are 
mostly microcystic tubules and glands which are often small and 
their cell lining is compressed [11,26]. 
Immunohistochemistry can be very valuable in distinguishing 
primary ovarian tumours from metastatic tumours [26]. Tumours 
are stained with Periodic Acid-Schiff with Diastase (PAS-D). 
Immunohistochemical staining is performed on formalin-fixed, 
paraffin-embedded tissue sections using the antibodies specific 
for the antigens, Cytokeratin 7 (CK7) and Cytokeratin 20 (CK20) 
[36]. A CK7+/CK20− immunophenotype favours a primary ovarian 
carcinoma, while, on the contrary, a CK7−/CK20+ or CK7+/
CK20+ immunophenotype (CK20 positivity, in particular) favours 
a metastatic gastrointestinal carcinoma [37].
The presence of a tumour can be detected by markers. None of 
these substances can be used as prevention or screening, but 
they can be used to strengthen or confirm a diagnosis (in our case, 
the markers were within the limits). The tumour markers, CA125 
and HE4, are currently included in the "Risk of Ovarian Malignancy 
Algorithm" (ROMA) for discerning benign from malignant pelvic 
masses. ROMA is an innovative calculation based on the values 
obtained from the HE4 and CA125 markers, and it provides 
a numeric value that classifies a patient based on her risk of 
developing ovarian cancer [38].
A Krukenberg tumour should be treated with excision of the 
primary tumour and ovarian metastasectomy if other dissemination 
or ascites are absents, to lengthen the survival time especially 
in patients with primitive tumour arising from the stomach [39]. 
Numerous studies have examined the issue of metastasectomy 
and cytoreductive surgery for Krukenberg tumours (including 
palliate symptoms). The concerns regarding surgical complications 
are relatively modest because metastasectomy for Krukenberg 
tumours is a sufficiently safe surgical procedure with a short 
postoperative hospital stay [40]. 
Majority of patients undergo chemotherapy with a platinum 
agent such as cisplatin or oxaliplatin and plus 5-fluorouracil. 
Platinum-based therapy continues to be the principal regimen 
used for disease that recurs ≥6 months after prior therapy. In non-
randomized studies, the response rate to platinum analogues is 
greater than non-platinum therapies [40,41]. The median survival 
time after the diagnosis of a Krukenberg tumour is reported to be 
from 7 to 14 months [40,42]. 
A Pubmed research using the keywords “krukenberg tumour”, 
“ovarian metastasis” and “gastric cancer” led us to evaluate both 
cases report and research studies, from 2005 to 2015. Only 
cases which reported patient’s age, clinical presentation, therapy 
and follow-up were considered and these consisted of 22 cases 
[Table/Fig-6] [4,8,9,12-14,17-30,43]. 
CoNCLUsIoN
Krukenberg tumour is a rare disease with a rapid progression. It 
is characterized by the presence of mucin-producing signet ring 
cells that are mostly metastases of gastrointestinal tract. The 
diagnosis of the primary site of the lesion is crucial in this tumour 
but, despite the recognition of the primary lesion and targeted 
therapy, the prognosis remains very poor. In our case the patient 
remained clinically stable for 26 months until she experienced a 
rapid deterioration of her clinical conditions over the course of 10 
days. She suddenly died due to a several cerebral haemorrhage.
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reference age Clinical presentation others factors Side extend of disease treatment Follow-up
Yamagishi [17]
2005
40 yrs Abdominal pain Pleural effusion Bilateral Gastric cancer HSO
CT
Died 28 
months after
Cetin [12]
2005
47 yrs Abdominal pain Pseudomeigs’ 
syndrome
Bilateral Gastric cancer
Liver and
Peritoneal metastases
G
HSO
MTS1
CT
Died 36 
months after
Chicos [18]
2007
62 yrs Abdominal discomfort ascites Bilateral Gallbladder cancer MTS2
HSO
Died 5 
months after
Ozdegirmenci [19] 
2007
22 yrs Pelvic pain Virilization, ascites, Bilateral Gastric cancer HSO
CT
Died 5 
months after
Reichert [43]
2007
43 yrs Pelvic mass Periaortic lymph node 
mass,anemia, leukemia
Left Confined to ovary HSO Died 3 
months after
Baba [20]
2007
53 yrs Lower abdominal mass Helicobacter pylori 
infection, pericardial 
effusion
Bilateral Gastric cancer and lymph 
node
G
MTS3
CT
Died15 
months after
Uharcek [21]
2007
52 yrs Abdominal mass Peritonitis 
carcinomatosa
Bilateral Appendix, omentum HSO
MTS4
CT
Died 18 
months after
Hornung [22]
2008
41 yrs Hypermenorrea, abdominal 
discomfort, nausea, emesis
Virilization Bilateral Gastric cancer, intestine 
cancer
CT
HSO
Died 6 
months after
Bilbao [23]
2008
45 yrs Lower abdominal pain Hepatomegaly, ascites Bilateral Hepatocarcinoma left hepatectomy
HSO
MTS5
CT
Died
Stojnic [24]
2011
31 yrs Pregnancy, ascites Bilateral Gastric cancer CES
HSO
MTS6
CT
Neonate died;
patient died 6
 months after
Habib [25]
2012
35 yrs Abdominal pain Right Gastric cancer HSO
CT
Died
Habib [25]
2012
55 yrs Epigastric pain ascites Bilateral Pancreas cancer
Peritoneal dissemination
HSO
CT
Died
Nakamura [14]
2014
45 yrs Lower Abdominal mass Hepatitis B, pleural 
effusion, ascites, 
chronic gastitis
Left Bones, Gastric cancer 
after biopsy
HSO
CT
Died
Shiono [26]
2014
44 yrs Epigastric pain, abdominal mass ascites Bilateral Colon cancer,
multiple liver metastases
HSO
MTS7
CT
Died 34 
months
after
Co PV [9]
2014
38 yrs Abdominal pain, nausea, bilious 
vomiting
Pregnancy, ascites Left Omentum and gastric 
cancer
CT Died
Hatwal [27]
2014
25 yrs Abdominal distension and pain, 
amenorrhea
abdominal lump
Bilateral Gastric cancer HSO Died after few 
months of 
surgery
Sun [8]
2015
35 yrs Abdominal pain Pregnancy, colon 
cancer history
right CES
HSO
CT
Died after 19 
months
Sahin [28]
2015
36 yrs metrorrhagia,
pelvic pain and discomfort during 
urination, abdominal mass
ascites Bilateral  Colon cancer HSO
CT
MTS8
Lives after  6 
months
Fujimoto [29]
2015
58 yrs Gastric cancer anaemia left Colon cancer G
OOP
MTS9
CT
Lives after 60 
months
Hiremath [4]
2015
39 yrs Amenorrhea, abdominal Pain, 
nausea, night sweats, loss of weight 
and appetite, abdominal mass
bilateral pleural 
effusion,
anaemia
bilateral Hepatic nodules,
Gastric cancer, lymph 
nodes
OOP
CT
Lived after 4 
months
Berthè [30]
2015
32 yrs Ascites, fever, Epigastric pain, pelvic 
pain
Constipation, cardial 
incontinence Pyloric 
Stenosis
bilateral Gastric cancer, peritoneal 
carcinomatosis, omentum, 
hepatic nodules
CT Died after 1 
month
Horimatsu [13]
2015
50 yrs abdominal fullness, dyspnea Pseudomeigs’ 
syndrome
bilateral Gastric cancer,
Lymph nodes
OOP
CT
Died after 27 
months
Spinelli 2016 60 yrs Pelvic discomfort, weight loss, 
metrorrhagia
bilateral Gastric cancer, bones, 
lymph node
HSOMTS10
CT
Lives after 15 
months
[table/Fig-6]: Clinical features of patients with Krukenberg tumours from review of literature from 2005 to 2015 [4,8,9,12,14,17-30,43].
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